Predictions
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€2.25
24.05.24
24.05.24
-
24.05.25
24.05.25
-2.45%
25.05.24
25.05.24
Verastem Inc.
Start price
Target price
Perf. (%)
€5.80
29.11.23
29.11.23
-
29.11.24
29.11.24
-28.62%
25.05.24
25.05.24
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€464.75
24.05.24
24.05.24
88.34%
25.05.24
25.05.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€462.89
24.05.24
24.05.24
88.34%
25.05.24
25.05.24
Novavax Inc.
Start price
Target price
Perf. (%)
€12.15
13.05.24
13.05.24
-
13.05.25
13.05.25
16.83%
25.05.24
25.05.24
Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.15
12.05.24
12.05.24
-
12.05.25
12.05.25
-21.69%
24.05.24
24.05.24
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.14
15.05.24
15.05.24
-
15.05.25
15.05.25
-16.67%
24.05.24
24.05.24
Risky Investment
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.27
23.05.24
23.05.24
-
23.05.25
23.05.25
67.32%
24.05.24
24.05.24
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.05
20.05.23
20.05.23
-
20.05.24
20.05.24
-63.97%
21.05.24
21.05.24
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.18
31.03.24
31.03.24
€6.00
31.03.25
31.03.25
-31.58%
20.05.24
20.05.24